CT Collateral Score in Acute Ischemic Stroke
The CT collateral score is a critical prognostic marker that independently predicts functional outcomes, infarct progression, and mortality in acute ischemic stroke patients, with good collaterals (typically score >3 on multiphase CTA) correlating with smaller infarct volumes, better 90-day functional independence, and greater benefit from reperfusion therapy including thrombectomy. 1
What the Collateral Score Measures
The collateral score quantifies the extent and quality of alternative blood flow pathways that bypass an occluded vessel to supply ischemic brain tissue. 2 This assessment can be performed using:
- Multiphase CT angiography (mCTA): Provides time-resolved depiction of collaterals through multiple phases, allowing semiquantitative grading with superior accuracy compared to single-phase techniques 2
- Single-phase CTA: Less accurate and tends to underestimate collateral status compared to mCTA 3
- CT perfusion (CTP): Can quantify collateral flow through parameters like maximum cerebral blood flow in collateral vessels 4
- Digital subtraction angiography (DSA): Considered the gold standard but invasive 2, 5
Prognostic Significance for Clinical Outcomes
Good collateral circulation independently predicts favorable functional outcome at 90 days after thrombectomy, even after adjusting for baseline stroke severity and recanalization success. 1, 6
Specific Outcome Predictions:
- Functional independence: Patients with good collaterals (mCTA score >3) have 84.8% sensitivity for achieving 90-day modified Rankin Scale (mRS) score of 0-2 3
- Hemorrhagic transformation risk: Higher collateral scores significantly correlate with lower risk of symptomatic intracerebral hemorrhage (sICH) 6, 4
- Infarct volume: Better collaterals correlate with smaller infarcts on CT and lower stroke scale scores 1
- Treatment benefit: Patients with good collaterals on baseline mCTA are more likely to benefit from endovascular thrombectomy (EVT) 2
Optimal Scoring Thresholds
A multiphase CTA collateral score of >3 optimally identifies patients with target mismatch on CT perfusion and predicts good clinical outcome. 3 This threshold provides:
- 78.4% sensitivity and 90.9% specificity for identifying target mismatch 3
- 84.8% sensitivity and 69.4% specificity for predicting 90-day mRS score of 0-2 3
The diagnostic efficacy of mCTA collateral score (AUC 0.697-0.902) is comparable to CT perfusion target mismatch assessment. 6, 3
Advantages of Multiphase CTA Over Single-Phase
Multiphase CTA should be the preferred method for collateral assessment because it:
- Predicts patient outcome better than single-phase CTA and CTP 2
- Has good interrater reliability 2
- Covers the whole brain 2
- Is robust against patient motion 2
- Requires no post-processing 2
- Provides useful information about extracranial vessel anatomy and clot length for procedural planning 2
Single-phase CTA significantly underestimates collateral status compared to mCTA (p < 0.01). 3
Impact on Treatment Decisions
For Thrombectomy Eligibility:
Collateral status should be integrated into treatment decision-making, particularly for patients with low ASPECTS scores or extended time windows. 1 The American Heart Association recommends that:
- Good collaterals predict benefit from reperfusion therapy even in patients with ASPECTS <6 1
- Collateral assessment helps distinguish fast versus slow progressors 1
- In posterior circulation strokes, a 6-point CTA collateral score correlates with good outcomes after thrombectomy 1
For Risk Stratification:
- Patients with poor collaterals have higher risk of hemorrhagic transformation and poor functional outcome despite treatment 2
- The collateral score has good application value in risk-benefit evaluation after mechanical thrombectomy 6
Critical Caveats and Pitfalls
Location-Dependent Effects:
Excellent collaterals do not guarantee good outcomes in all cases. 1 A proximal MCA occlusion may occlude lenticulostriate arteries supplying the basal ganglia and internal capsule—structures that cannot be collateralized from the cortex. 2, 1 Therefore, excellent transcortical collaterals might preserve cortex but permanent hemiplegia can still result from infarction of the internal capsule. 2, 1
Recanalization Dependency:
The benefit of collaterals depends on achieving successful recanalization—collaterals alone without reperfusion do not guarantee good outcomes. 1 This emphasizes that collateral assessment should guide but not replace the decision to pursue reperfusion therapy.
Technical Limitations:
- Extracranial stenoses and poor cardiac output can lead to underestimation of collaterals on mCTA 2
- Collaterals can fail over time, though late window patients still show diverse collateral grades 1
- CTP is subject to technical failures in up to 30% of patients and lacks standardized quantification 2
Practical Implementation
Grading System:
The proposed grading system evaluates collateral function based on:
- Extent of collateral filling to the ischemic territory 2
- Time to collateral filling compared to the contralateral hemisphere 2
- Slow collateral flow: filling >2 seconds slower than contralateral side 2
- Rapid collateral flow: filling within 2 seconds of contralateral side 2
Reading Efficiency:
Automated assistance software (e-CTA) can improve collateral scoring accuracy from 58.6% to 67.5% (p = 0.003), reduce reading time from 103.4 to 59.7 seconds (p = 0.001), and increase inter-rater agreement (Krippendorff's alpha from 0.366 to 0.676). 7
Integration with Other Imaging Markers
Collateral assessment should complement, not replace, ASPECTS scoring and clinical evaluation. 8 While ASPECTS quantifies early ischemic changes, collateral scores provide dynamic information about tissue viability and perfusion status. 2 The combination of ASPECTS and collateral scoring provides more comprehensive risk stratification than either alone. 1, 8
DWI-MRI remains the gold standard for ischemic core assessment, but mCTA collateral scoring offers a faster, more practical alternative in the emergency setting. 2